🧑‍🚀 Top 3 Deals You Can’t Miss

1️⃣ Nebius – $3.75B capital raise + $17.4B Microsoft contract to scale AI infrastructure.

2️⃣ Perplexity – $200M funding at ~$20B valuation, cementing its position in the AI search race.

3️⃣ Replit – $250M raise at $3B valuation, fueling its agentic AI creation platform.

🧠 Dopamine Dealflow

🌳 Series B+ & Growth

• Kriya Therapeutics (Research Triangle Park, NC) – $320M Series D; gene therapies for chronic diseases.

• Replit (San Francisco, CA) – $250M funding at $3B valuation; agentic AI software creation platform.

• Perplexity (San Francisco, CA) – $200M funding at ~$20B valuation; AI search engine.

• Odyssey Therapeutics (Boston, MA) – $213M Series D; clinical-stage biopharma.

• CuspAI (Cambridge, UK) – $100M Series A; AI for materials discovery.

• Nitricity (Fremont, CA) – $50M Series B; electrifying nitrogen fertilizer production.

• PixVerse (Singapore) – $60M Series B; AI video platform.

• Koi (Washington, DC) – $48M across seed + Series A; endpoint security.

• Noxilizer (Hanover, MD) – $30M funding; nitrogen dioxide-based sterilization for biopharma/med devices.

• Brain.co (NYC, NY) – $30M Series A; AI deployments for governments & corporates.

• Pest Share (Nampa, ID) – $28M Series A; on-demand pest control for property managers.

• Optain Health (NYC, NY) – $26M Series A; AI-driven retinal imaging + teleophthalmology.

• Clyx (NYC, NY) – $14M Series A; Gen Z real-life social experiences platform.

• Accordance (San Francisco, CA) – $13M funding; AI-native accounting/tax platform.

• Standard Fleet (San Francisco, CA) – $13M Series A; fleet management for connected vehicles.

• Lōvu Health (Cupertino, CA) – $8M Series A; digital maternal health platform.

• SafeHeal (Paris, France) – $10M extension of €35M Series C; medical device for gastrointestinal recovery.

• CUTISS (Zurich, Switzerland) – CHF 56M Series C; tissue therapeutics + regenerative medicine.

🚀 Series A

• Red Access (Tel Aviv, Israel) – $17M Series A; agentless browser + SaaS security.

🌱 Seed & Early Rounds

• AegisAI (NYC, NY) – $13M Seed; AI-powered email security.

• TrueMeter (San Francisco, CA) – $4M Seed; AI-driven energy savings automation.

• OpenHealth Technologies (Berlin, Germany) – $3M Seed; lab data infrastructure.

• LocusX (Montreal, Canada) – CAD $3M Seed; AI-powered issue resolution for video games.

• Rendezvous Robotics (Golden, CO) – $3M Pre-Seed; autonomous in-orbit assembly.

• TwinMind (US-based) – $5.7M Seed; “second brain” AI app, ambient speech + personal context graph.

• Podonos (Los Gatos, CA) – $2.4M Pre-Seed; infrastructure for evaluating voice AI.

• Procense (San Francisco, CA) – $1.5M Seed; AI + remote sensing for industrial automation.

• AnthroTek (Cambridge, UK) – £950K Seed; synthetic anatomy tech.

• Tipple (Dublin, Ireland) – €4M Seed; digital infra for alcohol industry.

• Hush Security (Tel Aviv, Israel) – $11M Seed; machine identity security platform.

🤝 Strategic, M&A & Undisclosed

• Anglo American + Teck Resources – $53B merger to form “Anglo Teck”; copper & critical minerals giant.

• Nebius (Amsterdam / Global) – $17.4B, 5-year strategic infra contract with Microsoft for AI cloud infra.

• Raken (San Diego, CA) – Investment from Sverica Capital; field management software for construction.

• e-PlanSoft (Irvine, CA) – Growth investment from ParkerGale; electronic plan review software.

📈 IPOs / Direct Listings / Issuances / Block Trades

• Nio – $1B raised in share sale; Chinese EV maker.

• Pattern – Filed for $321.4M IPO; e-commerce reseller.

• Kansai Electric – Elliott took 5% activist stake; Japanese utility.

💸 VC Funds Raised & Raising

• Veritas Capital (NYC, NY) – Closed Fund IX at $14.4B; tech + gov-focused PE.

• One Equity Partners (NYC, NY) – Closed Fund IX at $3.25B; middle-market PE.

• TVM Capital Healthcare – First close of $150M Southeast Asia healthcare growth fund.

• Vireo Ventures (Berlin, Germany) – Closed Electrification Fund I at €50M; energy transition focus.

• Cloud Capital (NYC & San Francisco, CA) – Closed Fund II; global data center infra.

Founders: Want to be featured on @tradedvc? → traded.co/submit/vc

📚 Read of the Day

🍏 Apple Edges Toward the $2,000 iPhone

Cupertino is quietly testing just how high the market will go.

The Strategy

Apple isn’t just raising prices — it’s reframing the iPhone as a super-premium device that could sit closer to luxury watches and cars than everyday smartphones. By introducing incremental “price normalizations,” Apple tests loyalty and gauges how much of its 1.5B-device ecosystem will pay up for status + power.

The Backstory

iPhone ASPs (average selling prices) have been steadily increasing from under $700 five years ago to over $1,000 today. With inflation, AI hype, and the Vision Pro setting a precedent for ultra-high pricing, Apple sees room to push its flagship well above historical norms.

Why It Matters

For founders and investors, Apple’s strategy signals a consumer willingness to absorb premium hardware pricing if the value proposition (status, AI, mixed reality) is strong enough. This creates tailwinds for startups building luxury-tech experiences — whether in devices, AI interfaces, or consumer health — where margin expansion can offset slower unit growth.

👉 Read The Whole Story Here

📰 News You Don’t Want To Miss

🍏 Apple starts getting customers used to the idea of $2,000 iPhones

🇨🇳 Chinese data center firm ZData seeks $500M private loan

🏢 Vantage Data Centers raises $1.6B from GIC and Abu Dhabi

🚁 Uber will add Blade’s helicopters to its platform as early as 2026